Ben is a partner and head of the Healthcare sector at Inflexion where he is responsible for sourcing, evaluating and leading majority and minority investment opportunities in this sector.

Ben led our investment in CNX, Rosemont Pharmaceuticals, Ridgewall, Pharmaspectra, European LifeCare Group, Lintbells and SteriPack.

Before joining Inflexion in 2017 Ben was a partner at Duke Street Private Equity and worked across Europe on a number of deals in the healthcare sector, including the acquisitions of Baywater Healthcare in the UK and Medi-Globe in Germany. Ben began his career in private equity since in 2006 at Barclays Capital, where he worked in their Principal Investments Area. He went on to private investment vehicle Echelon Capital, where he completed private equity deals in the retail, leisure and TMT space.

When not at work Ben enjoys travelling to exotic parts of the globe.

He has a first class degree in Modern History from Oxford.